Cevimeline Sulfoxide Impurity 1 - Request Quote
Cevimeline Sulfoxide Impurity 1
| SZ CAT No: | SZ-C017028 |
| CAS No | NA |
| Mol.F. | C10H17NO2S |
| Mol.Wt. | 215.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cevimeline Sulfoxide Impurity 1 is chemically (2S,3'S,5'S)-5'-methyl-4-azaspiro[bicyclo[2.2.2]octane-2,2'-[1,3]oxathiolane] 3'-oxide. Cevimeline Sulfoxide Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Cevimeline Sulfoxide Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cevimeline.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Cevimeline Sulfoxide Impurity 1
Purchase Cevimeline Sulfoxide Impurity 1
Cevimeline Sulfoxide Impurity 1 suppliers
Cevimeline Sulfoxide Impurity 1 manufacturers
Cevimeline Sulfoxide Impurity 1 price
Order Cevimeline Sulfoxide Impurity 1
Enquire Cevimeline Sulfoxide Impurity 1
Cevimeline Sulfoxide Impurity 1 cost
Cevimeline Sulfoxide Impurity 1 Supplier
Cevimeline Sulfoxide Impurity 1 Distributor
Cevimeline Sulfoxide Impurity 1 for Method Validation
Cevimeline Reference Standard
Cevimeline Sulfoxide Impurity 1 for ANDA Filing
Cevimeline Sulfoxide Impurity 1 for Forced Degradation Studies
Cevimeline Sulfoxide Impurity 1 Identification Standards
Cevimeline Sulfoxide Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


